CORRECTING and REPLACING Ligand Presentation at JP Morgan Healthcare C

    Business Editors/Health/Medical Writers
    CORRECTION...by Ligand Pharmaceuticals
    JPMorgan Annual Healthcare Conference 2005
    BIOWIRE2K

    SAN DIEGO--(BUSINESS WIRE)--Jan. 10, 2005--In BW6011 issued Jan. 10, 2005: First graph, first sentence of the release should read: Thursday, January 13 (sted Wednesday).
    The corrected release reads:

    LIGAND PRESENTATION AT JP MORGAN HEALTHCARE CONFERENCE TO BE WEB CAST JANUARY 13

    Ligand Pharmaceuticals (Nasdaq:LGND) announced today that its presentation at JP Morgan Healthcare Conference in San Francisco will be web cast live on Thursday, January 13, at 9:00 a.m. Pacific time.
    The web cast may be accessed live at http://equityconferences.jpmorgan.com (select "Ligand Pharamceuticals" from the list of presenting companies). The presentation will be archived on the site until January 21, 2005.

    About Ligand

    Ligand discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to Intracellular Receptors (IRs) and Signal Transducers and Activators of Transcription (STATs). For more information, go to www.ligand.com.

--30--WAM/la*

CONTACT: Ligand Pharmaceuticals Incorporated Abe Wischnia, 858-550-7850

KEYWORD: CALIFORNIA TRACK INDUSTRY KEYWORD: PHARMACEUTICAL MEDICAL BIOTECHNOLOGY TRADESHOW CONFERENCE CALLS SOURCE: Ligand Pharmaceuticals Incorporated

Copyright Business Wire 2005